101
|
Angelis V, Hunter S, Shah R. First line anti-PD1 checkpoint inhibitor in the management of patients with advanced non-small cell lung cancer: the Kent Cancer Network experience. Lung Cancer 2019. [DOI: 10.1016/s0169-5002(19)30140-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
102
|
Krishnamoorthy B, Critchley WR, Soon SY, Birla R, Begum Z, Nair J, Devan N, Mohan R, Fildes J, Morris J, Fullwood C, Krysiak P, Malagon I, Shah R. A Randomized Study Comparing the Incidence of Postoperative Pain After Phrenic Nerve Infiltration Vs Nonphrenic Nerve Infiltration During Thoracotomy. Semin Thorac Cardiovasc Surg 2018; 31:583-592. [PMID: 30529157 DOI: 10.1053/j.semtcvs.2018.11.014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2018] [Accepted: 11/30/2018] [Indexed: 11/11/2022]
Abstract
Thoracotomy is a common surgical procedure performed worldwide for lung disease. Despite major advances in analgesia, patients still experience severe shoulder, central back and surgical incision site pain in the postoperative period. This study aimed to assess whether intraoperative phrenic nerve infiltration reduces the incidence of postoperative pain and improves peak flow volume measurements during incentive spirometry. 90 patients undergoing open lobectomy were randomly assigned to have phrenic nerve infiltration (n = 46) or not (n = 44). The phrenic nerve infiltration group received 10 mL of 0.25% bupivacaine into the periphrenic fat pad. Preoperative assessments of spirometry and pain scores were recorded (at rest and with movement). Postoperative assessments included peak flow and pain measurements at intervals up to 72 hours. Less shoulder pain was experienced with phrenic nerve infiltration up to 6 hours postsurgery at rest (P = 0.005) and up to 12 hours with movement (P < 0.001). Reduced back pain was reported in the phrenic nerve infiltration group up to 6 hours after surgery both at rest (P = 0.001) and with movement (P = 0.00). Phrenic nerve infiltration reduced pain at the incision site for up to 3 hours both at rest (P < 0.001) and with movement (P = 0.001). Spirometry readings dropped in both groups with consistently lower readings at baseline and follow-up in the PNI group (P = 0.007). Lower analgesic usage of patient controlled analgesia morphine (P < 0.0001), epipleural bupivacaine (P = 0.001), and oramorph/zomorph (P = 0.0002) were recorded. Our findings indicate that the use of phrenic nerve infiltration significantly reduced patient pain scores during the early postoperative period, particularly during movement. We believe that each technique has advantages and disadvantages; however, further studies with large sample size are warranted.
Collapse
|
103
|
Shah R, Brodsky SV, Hebert L, Rovin BH, Nadasdy T, Satoskar AA. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies. Lupus 2018; 27:2236-2244. [PMID: 30403144 DOI: 10.1177/0961203318809177] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Antiphospholipid antibody syndrome (APS) is an acquired prothrombotic autoimmune disease caused by the presence of antibodies against anionic phospholipids or plasma proteins bound to phospholipids on cell membranes. It can be a primary disease or secondary to other autoimmune diseases, most commonly systemic lupus erythematosus (SLE). Laboratory testing for antiphospholipid antibodies (aPL) may be only transiently positive, so APS could be missed until a catastrophic thrombotic episode or pregnancy morbidity occurs. In the kidneys, this manifests as thrombotic microangiopathy (TMA), and patients present with hypertensive urgency and acute kidney injury. However, APS may not always have a catastrophic presentation but instead a more smoldering course. Kidney biopsy may not show obvious active TMA lesions but rather only chronic injury in the form of zonal cortical scarring and tubular thyroidization. Still, it may warrant anticoagulation therapy. So it is important to recognize this pattern of injury in the biopsy. Herein, we retrospectively study the correlation between presence of this histologic feature in kidney biopsies of SLE patients and positive aPL testing results (anticardiolipin antibodies and/or lupus anticoagulant). Kidney biopsies of SLE patients from 2004 to 2015 ( n = 186) were screened for presence or absence of zonal cortical scarring. Their electronic medical records were reviewed for aPL results. Our study showed low sensitivity (33%) but higher positive predictive value (62%), specificity (89%) and negative predictive value (71%). This histologic finding is therefore not a sensitive screening tool, but if present, greatly increases the likelihood of underlying aPL. We want to emphasize that recognition of this histologic feature in the biopsies of SLE patients is important so as not to miss the opportunity to treat with anticoagulation therapy and possibly slow down the chronic renal damage.
Collapse
|
104
|
Cho B, Cheng Y, Zhou C, Ohe Y, Imamura F, Lin MC, Majem M, Shah R, Rukazenkov Y, Todd A, Markovets A, Barrett C, Chmielecki J, Gray J, Ramalingam S. Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy483.007] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
105
|
Hermann G, Prezzano K, Shah R, Strode M, Iovoli A, Kane J, Salerno K. Adjuvant Regional Nodal Radiation in Sentinel Lymph Node Positive Merkel Cell Carcinoma without Completion Lymph Node Dissection. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
106
|
Epps F, Kilgore K, Phillips J, Shah R, Hepburn K. RECRUITING FROM A DISTANCE: USING A HANDSHAKE PROTOCOL TO IMPROVE ENROLLMENT IN TELEHEALTH INTERVENTIONS. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.1163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
107
|
Shah R, Chou L, Kuo Y, Raji M. LONG-TERM OPIOID THERAPY IN OLDER CANCER SURVIVORS: A RETROSPECTIVE COHORT STUDY. Innov Aging 2018. [DOI: 10.1093/geroni/igy031.3636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
108
|
Abe K, Akutsu R, Ali A, Amey J, Andreopoulos C, Anthony L, Antonova M, Aoki S, Ariga A, Ashida Y, Azuma Y, Ban S, Barbi M, Barker GJ, Barr G, Barry C, Batkiewicz M, Bench F, Berardi V, Berkman S, Berner RM, Berns L, Bhadra S, Bienstock S, Blondel A, Bolognesi S, Bourguille B, Boyd SB, Brailsford D, Bravar A, Bronner C, Buizza Avanzini M, Calcutt J, Campbell T, Cao S, Cartwright SL, Catanesi MG, Cervera A, Chappell A, Checchia C, Cherdack D, Chikuma N, Christodoulou G, Coleman J, Collazuol G, Coplowe D, Cudd A, Dabrowska A, De Rosa G, Dealtry T, Denner PF, Dennis SR, Densham C, Di Lodovico F, Dokania N, Dolan S, Drapier O, Duffy KE, Dumarchez J, Dunne P, Emery-Schrenk S, Ereditato A, Fernandez P, Feusels T, Finch AJ, Fiorentini GA, Fiorillo G, Francois C, Friend M, Fujii Y, Fujita R, Fukuda D, Fukuda Y, Gameil K, Giganti C, Gizzarelli F, Golan T, Gonin M, Hadley DR, Haegel L, Haigh JT, Hamacher-Baumann P, Hansen D, Harada J, Hartz M, Hasegawa T, Hastings NC, Hayashino T, Hayato Y, Hiramoto A, Hogan M, Holeczek J, Hosomi F, Ichikawa AK, Ikeda M, Imber J, Inoue T, Intonti RA, Ishida T, Ishii T, Ishitsuka M, Iwamoto K, Izmaylov A, Jamieson B, Jiang M, Johnson S, Jonsson P, Jung CK, Kabirnezhad M, Kaboth AC, Kajita T, Kakuno H, Kameda J, Karlen D, Katori T, Kato Y, Kearns E, Khabibullin M, Khotjantsev A, Kim H, Kim J, King S, Kisiel J, Knight A, Knox A, Kobayashi T, Koch L, Koga T, Koller PP, Konaka A, Kormos LL, Koshio Y, Kowalik K, Kubo H, Kudenko Y, Kurjata R, Kutter T, Kuze M, Labarga L, Lagoda J, Lamoureux M, Lasorak P, Laveder M, Lawe M, Licciardi M, Lindner T, Liptak ZJ, Litchfield RP, Li X, Longhin A, Lopez JP, Lou T, Ludovici L, Lu X, Magaletti L, Mahn K, Malek M, Manly S, Maret L, Marino AD, Martin JF, Martins P, Maruyama T, Matsubara T, Matveev V, Mavrokoridis K, Ma WY, Mazzucato E, McCarthy M, McCauley N, McFarland KS, McGrew C, Mefodiev A, Metelko C, Mezzetto M, Minamino A, Mineev O, Mine S, Missert A, Miura M, Moriyama S, Morrison J, Mueller TA, Murphy S, Nagai Y, Nakadaira T, Nakahata M, Nakajima Y, Nakamura KG, Nakamura K, Nakamura KD, Nakanishi Y, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Niewczas K, Nishikawa K, Nishimura Y, Nonnenmacher TS, Novella P, Nowak J, O'Keeffe HM, O'Sullivan L, Okumura K, Okusawa T, Oryszczak W, Oser SM, Owen RA, Oyama Y, Palladino V, Palomino JL, Paolone V, Paudyal P, Pavin M, Payne D, Pickering L, Pidcott C, Pinzon Guerra ES, Pistillo C, Popov B, Porwit K, Posiadala-Zezula M, Pritchard A, Quilain B, Radermacher T, Radicioni E, Ratoff PN, Reinherz-Aronis E, Riccio C, Rondio E, Rossi B, Roth S, Rubbia A, Ruggeri AC, Rychter A, Sakashita K, Sánchez F, Sasaki S, Scantamburlo E, Scholberg K, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaikhiev A, Shaker F, Shaw D, Shiozawa M, Smirnov A, Smy M, Sobczyk JT, Sobel H, Sonoda Y, Steinmann J, Stewart T, Stowell P, Suda Y, Suvorov S, Suzuki A, Suzuki SY, Suzuki Y, Sztuc AA, Tacik R, Tada M, Takeda A, Takeuchi Y, Tamura R, Tanaka HK, Tanaka HA, Thakore T, Thompson LF, Toki W, Touramanis C, Tsui KM, Tsukamoto T, Tzanov M, Uchida Y, Uno W, Vagins M, Vallari Z, Vasseur G, Vilela C, Vladisavljevic T, Volkov VV, Wachala T, Walker J, Wang Y, Wark D, Wascko MO, Weber A, Wendell R, Wilking MJ, Wilkinson C, Wilson JR, Wilson RJ, Wret C, Yamada Y, Yamamoto K, Yamasu S, Yanagisawa C, Yang G, Yano T, Yasutome K, Yen S, Yershov N, Yokoyama M, Yoshida T, Yu M, Zalewska A, Zalipska J, Zaremba K, Zarnecki G, Ziembicki M, Zimmerman ED, Zito M, Zsoldos S, Zykova A. Search for CP Violation in Neutrino and Antineutrino Oscillations by the T2K Experiment with 2.2×10^{21} Protons on Target. PHYSICAL REVIEW LETTERS 2018; 121:171802. [PMID: 30411920 DOI: 10.1103/physrevlett.121.171802] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/22/2018] [Indexed: 06/08/2023]
Abstract
The T2K experiment measures muon neutrino disappearance and electron neutrino appearance in accelerator-produced neutrino and antineutrino beams. With an exposure of 14.7(7.6)×10^{20} protons on target in the neutrino (antineutrino) mode, 89 ν_{e} candidates and seven anti-ν_{e} candidates are observed, while 67.5 and 9.0 are expected for δ_{CP}=0 and normal mass ordering. The obtained 2σ confidence interval for the CP-violating phase, δ_{CP}, does not include the CP-conserving cases (δ_{CP}=0, π). The best-fit values of other parameters are sin^{2}θ_{23}=0.526_{-0.036}^{+0.032} and Δm_{32}^{2}=2.463_{-0.070}^{+0.071}×10^{-3} eV^{2}/c^{4}.
Collapse
|
109
|
Hayes A, Furnace M, Rundell C, Shah R, Muller G, Thirlwell C, Luong T, Toumpanakis C, Caplin M, Mandair D. The prognostic role of morphology and Ki67 in grade 3 gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy293.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
110
|
Shah R, Maizels M, Meade P, Suresh S. Regional nerve blocks in everyday pediatric urology: 2. Ultrasound-guided regional anesthetic caudal block. J Pediatr Urol 2018; 14:457-460. [PMID: 30502061 DOI: 10.1016/j.jpurol.2018.11.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/16/2018] [Accepted: 08/16/2018] [Indexed: 10/27/2022]
|
111
|
Nwankwo C, Shah R, Kwon Y, Corman S. Economic and humanistic burden of cervical cancer in the United States. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy285.188] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
112
|
Popat S, Januszewski A, Hughes L, O'Brien M, Ahmad T, Lewanski C, Dernedde U, Jankowska P, Mulatero C, Shah R, Hicks J, Geldart T, Cominos M, Gray G, Spicer J, Bell K, Roitt S, Howarth K, Cinelli M, Green E, Morris C, Ngai Y, Hackshaw A. P1.13-17 Multicentre Phase II Trial of First-Line Afatinib in Patients with Suspected/Confirmed EGFR Mutant NSCLC: ctDNA and Long-Term Efficacy. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.874] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
113
|
Ramalingam S, Cheng Y, Zhou C, Ohe Y, Imamura F, Cho B, Lin MC, Majem M, Shah R, Rukazenkov Y, Todd A, Markovets A, Barrett J, Chmielecki J, Gray J. Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy424.063] [Citation(s) in RCA: 168] [Impact Index Per Article: 28.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
114
|
McDaniel C, Holewa C, Dunlop N, Turvey T, Shah R. The Effects of Le Fort I Osteotomy on Alar Width after 1 Year. J Oral Maxillofac Surg 2018. [DOI: 10.1016/j.joms.2018.06.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
115
|
Hirji S, Landino S, Lee J, Shah R, McGurk S, Kaneko T, Shekar P, Pelletier M. CHRONIC OPIOID USE AFTER CORONARY ARTERY BYPASS SURGERY: ARE WE CONTRIBUTING TO THE EPIDEMIC? Can J Cardiol 2018. [DOI: 10.1016/j.cjca.2018.07.388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
116
|
Delius M, Rehfuess EA, Paudel D, Maskey MK, Shah R. Barriers to institutional delivery in rural areas of Chitwan district, Nepal: A qualitative study. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
117
|
Middleton G, Brock K, Summers Y, Connibear J, Shah R, Ottensmeier C, Shaw P, Ming-Lee S, Popat S, Barrie C, Barone G, Mant R, Savage J, Billingham L. Pembrolizumab in performance status 2 patients with non-small cell lung cancer (NSCLC): Results of the PePS2 trial. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy292.007] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
118
|
Escriu C, Sallam M, del Carpio L, Tokaca N, Solway L, Shah R, Fouzia A, Ghafoor Q, Popat S, Postmus P. Afatinib dose intensity and clinical efficacy in advanced EGFR-mutated non-small cell lung cancer: UK multicentre real-life data. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy292.075] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
119
|
Shah R, Horner S, Armstrong S, Sanders S. 124DAY HOSPITAL ALCOHOL CONSUMPTION REVIEW. Age Ageing 2018. [DOI: 10.1093/ageing/afy126.40] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
120
|
Ahmed A, Steed L, Burden-Teh E, Shah R, Sanyal S, Tour S, Dowey S, Whitton M, Batchelor J, Bewley A. Identifying key components for a psychological intervention for people with vitiligo - a quantitative and qualitative study in the United Kingdom using web-based questionnaires of people with vitiligo and healthcare professionals. J Eur Acad Dermatol Venereol 2018; 32:2275-2283. [PMID: 29972710 DOI: 10.1111/jdv.15168] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2017] [Accepted: 06/21/2018] [Indexed: 11/28/2022]
|
121
|
Nucifora G, Muser D, Tioni C, Shah R, Selvanayagam J. P4695Prognostic value of global circumferential strain as assessed by feature-tracking cardiac magnetic resonance in patients with a first st-segment elevation myocardial infarction. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4695] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
122
|
Szentgyorgyi L, Head L, Dosouto E, Shah R, Davies A. Post-intubation tracheal tear repair on VV-ECMO support. J Cardiothorac Vasc Anesth 2018. [DOI: 10.1053/j.jvca.2018.08.140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
123
|
Takeshita J, Eriksen W, Raziano V, Shah R, Bocage C, Gelfand J, Barg F. 271 Psoriasis patients perceptions of therapies differ by race. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.277] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
124
|
Shah R, Kroshinsky D. 502 Cyclosporine vs. IV corticosteroids for the management of SJS/TEN. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
125
|
Shah R, Strazzula L, Kroshinsky D. 347 Analysis of after hours paging: Dermatology consults and pages. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
126
|
Salem A, Gorman D, Mistry H, Joseph L, Shah R, Valentine H, Jackson A, West C, Faivre-Finn C, O'Connor J, Asselin M. OC-0267: Technical and biological validation of hypoxia PET imaging using [18F]fluroazomycin (FAZA) in NSCLC. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)30577-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
127
|
Venado A, Soong A, Shrestha P, Greenland J, Shah R, Hays S, Leard L, Golden J, Kukreja J, Katz P, McCulloch C, Singer J. The Clinical Trajectory of Frailty in Adults Undergoing Lung Transplantation. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
128
|
Laidlaw G, Sheu A, Fell J, Triana B, Goettl C, Shah R. Abstract No. 471 Development of a femoral vascular access curriculum: training medical students and residents for safe, real-world vascular access. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.516] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
129
|
AbdelRazek M, Khalaf M, Shah R, Jackson K, Desai M, Sundaram V, Kothary N. Abstract No. 509 Same-day discharge after chemoembolization: a predictive model to assist physicians in minimizing overnight admissions. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
130
|
Khalaf M, AbdelRazek M, Wang D, Shah R, Kothary N. 4:12 PM Abstract No. 330 Analgesic and antiemetic requirement for post-embolization syndrome after cTACE versus DEB-TACE. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
131
|
Aly A, Shah R, Hill K, Waldeck AR, Botteman M. Abstract P6-08-05: United States real-world drug utilization patterns and associated overall survival in Medicare patients with newly-diagnosed metastatic triple negative breast cancer using surveillance, epidemiology, and end results-Medicare data. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p6-08-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Limited information is available about treatment patterns for elderly patients (pts) with metastatic triple negative breast cancer (mTNBC). This analysis characterized real-world drug utilization patterns and associated overall survival (OS) for Medicare mTNBC pts.
Methods: Pts ≥66 years of age who were newly diagnosed with mTNBC between 2004 and 2011 were identified from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database. Triple negative status was obtained from the SEER registry, except for HER2 that was unavailable from 2004-2009 during which we assumed that pts who had a claim for a HER2 test followed by absence of hormonal therapy to be presumed HER2 negative. Pts were followed from diagnosis to death, Medicare disenrollment, HMO enrollment, or 12/31/2013 (whichever occurred first) to characterize the sequence of chemotherapy received – first regimen (1R), second regimen (2R), and third regimen (3R) and median (interquartile, IQR) duration of and between regimens. OS estimates were reported using the Kaplan-Meier method.
Results: Among 694 mTNBC pts, 69 died within 30 days of diagnosis and were excluded. In the remaining 625 pts observed from 2004 through 2013 (median age: 75 years; Charlson comorbidity index (CCI) ≥2: 21%; and median follow-up: 11.4 months), 317 (51%) received chemotherapy. Of the 317 pts, 161 got only 1R, 88 got only 2R, and 68 got 3R+. Compared to pts on 1R, pts on 2R were significantly younger (median age: 2R, 72; 1R, 75 years), married (2R, 40%; 1R, 30%), had fewer comorbidities (CCI≥2: 2R, 16%; 1R, 23%). The top 2 most commonly prescribed single agents in 1R, 2R, and 3R were: 1R, paclitaxel followed by capecitabine; 2R, capecitabine followed by paclitaxel; 3R, gemcitabine followed by capecitabine. The most common combination regimen given was taxane-based in 1R (57%) and 2R (70%).
Drug utilization patterns First Regimen (n=317)Second Regimen (n=156)Third Regimen (n=68)Single Agent205 (65%)74 (47%)40 (59%)Microtubule inhibitors80 (39%)23 (31%)NRPaclitaxel72 (35%)18 (24%)NRAnthracyclines29 (14%)13 (18%)NRDoxorubicin27 (13%)13 (18%)NRAntimetabolites/Others96 (47%)38 (51%)27 (73%)Capecitabine51 (25%)20 (27%)NRGemcitabineNRNR13 (35%)OthersNRNRNRCombination Regimens112 (35%)82 (53%)28 (41%)Taxane-based64 (57%)57 (70%)NRNR, not reported per DUA with NCI. %, col. % relative to single/comb. category
Median (IQR) durations of 1R, 2R, and 3R were 2.7 (1.4-4.4), 3.1 (1.6-5.0), and 2.3 (0.9-4.5) months, respectively. Median time from diagnosis to start of 1R was 1.6 (0.9-2.8) months. Median time to start of 2R and 3R after the end of the previous regimen was 4.6 (2.1-8.1), and 6.2 (3.3-11.0) months, respectively. The median (12-month) OS was 7 months (34%) for all pts and ranged from 3.5 (17%) in the untreated to 25.3 (88%) months in 3R+ pts.
Conclusions: About half of Medicare mTNBC pts do not receive chemotherapy in the real world. Paclitaxel and capecitabine were the most commonly used single agents and taxane-based combination therapy was the most commonly used combination.
Citation Format: Aly A, Shah R, Hill K, Waldeck AR, Botteman M. United States real-world drug utilization patterns and associated overall survival in Medicare patients with newly-diagnosed metastatic triple negative breast cancer using surveillance, epidemiology, and end results-Medicare data [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P6-08-05.
Collapse
|
132
|
Schommer E, Pathak R, McNulty Z, Shah R, Broderick G. 207 Single Center Experience Using Doppler Assessment for Erectile Dysfunction (ED) Complaint in More Than 500 Patients. J Sex Med 2018. [DOI: 10.1016/j.jsxm.2017.11.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
133
|
Domah F, Shah N, Domah J, Shah R. Medication-related osteonecrosis of the jaw - a current review. ACTA ACUST UNITED AC 2018. [DOI: 10.1111/ors.12329] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
134
|
Evans J, Kitson R, Shah R, Li S, Ghosh S, Pouptsis A, Ahmed S, Walter H, Ahmad T, Asghar U, Lester J, Newsom-Davis T. 30-day mortality following initiation of immunotherapy for advanced stage lung cancer. Lung Cancer 2018. [DOI: 10.1016/s0169-5002(18)30108-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
135
|
Shah R, Parnham S, Nucifora G, Liang Z, Shree Raman K, Woodman R, Gleadle J, Selvanayagam J. Prognostic Utility of Blood Oxygen Level-Dependent Cardiovascular Magnetic Resonance Imaging in Asymptomatic Patients with Chronic Kidney Disease with and Without Diabetes Mellitus. Heart Lung Circ 2018. [DOI: 10.1016/j.hlc.2018.06.496] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
136
|
Wakelin S, Bevans F, Gilham L, Smith A, Shah R. Incorporating the review of immunotherapy patients within an already established lung CNS nurse led clinic. Lung Cancer 2018. [DOI: 10.1016/s0169-5002(18)30137-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
137
|
Hirsh V, Tan E, Wu Y, Sequist L, Zhou C, Schuler M, Geater S, Mok T, Hu C, Yamamoto N, Feng J, O’Byrne K, Lu S, Huang Y, Sebastian M, Okamoto I, Dickgreber N, Shah R, Palmer M, Märten A, Massey D, Samuelsen C, Yang J. P3.01-075 Afatinib Dose Adjustment: Effect on Safety, Efficacy and Patient-Reported Outcomes in the LUX-Lung 3/6 Trials in EGFRm+ NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
138
|
Khajuria A, Shah R, Gbejuade H, Siddiqui S. Increasing Awareness of Compartment Syndrome amongst Orthopaedic Nurses and Trauma Nurse Practitioners at a District General Hospital: A Complete Audit Loop. Int J Surg 2017. [DOI: 10.1016/j.ijsu.2017.08.434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
139
|
Shah R. Very-long-term efficacy of bioresorbable vascular scaffolds. Neth Heart J 2017; 25:649. [PMID: 28983788 PMCID: PMC5653540 DOI: 10.1007/s12471-017-1041-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
140
|
Ma J, Bell A, Setton J, Haseltine J, Thompson M, Shah R, Lok B, Delsite R, Ellis M, Aft R, Riaz N, Powell S. In Vitro Characterization and Clinical Correlation of BRCAness as a Personalized Biomarker for Radiosensitization With Homologous Recombination Directed Therapies. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.2059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
141
|
Botteman M, Shah R, Gupte-Singh K, Luo L, Sabater J, Rao S, McDermott D, Atkins M, Regan M. Quality-adjusted survival of combined nivolumab plus ipilimumab (NIVO+IPI) or NIVO alone vs IPI among treatment-naïve patients (pts) with advanced melanoma (MEL): a quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx377.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
142
|
Gaikwad A, Khan S, Kadam S, Kadam K, Dighe V, Shah R, Kulkarni V, Kumaraswamy R, Gajbhiye R. The CFTR gene mild variants poly-T, TG repeats and M470V detection in Indian men with congenital bilateral absence of vas deferens. Andrologia 2017; 50. [PMID: 28776713 DOI: 10.1111/and.12858] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/26/2017] [Indexed: 11/30/2022] Open
Abstract
The aim of the study was to detect the frequency of the CFTR gene variants poly-T, TG repeats and c.1408A>G p.Met470Val (M470V) in Indian men with congenital bilateral absence of the vas deferens (CBAVD). Men diagnosed with CBAVD (n = 76), their female partners (n = 76) and healthy men from general population (n = 50) were recruited. Genomic DNA was isolated and the polymorphic regions of IVS9- c.1210-12T [5] and M470V were amplified using specific primers followed by Sanger's DNA sequencing. A statistically significant increase in the frequency of heterozygous IVS9- c.1210-12T [5] (39.4%) was observed in CBAVD men as compared to controls (14%). The allelic distribution of c.1210-12T [5], c.1210-12T [7] and c.1210-12T [9] in CBAVD men was 21%, 64.4% and 13% and that in healthy controls was 7%, 73% and 20% respectively. Longest TG repeat c.1210-34TG [13] was found in association with c.1210-12T [5] with an allelic frequency of 5.9% in CBAVD men. We found a significant association of c.1210-34TG [12]/c.1210-34TG [13] - c.1210-12[5] -V470 allele in CBAVD men. Twelve female partners harboured a heterozygous c.1210-12T [5] allele. The study emphasises the need to screen both partners for the polymorphisms M470V, poly-T, TG tract repeats in addition to population-specific known CFTR gene mutations.
Collapse
|
143
|
Perlman A, Shah R, Bennett D, Buchman A, Matok I. STATINS AND INCIDENT DISABILITY IN COMMUNITY-DWELLING OLDER ADULTS—A LONGITUDINAL STUDY. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.4682] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
144
|
Manning L, Shah R, Jimenez A, Wolfe M. PERCEPTIONS OF HEALTHY AGING: EXPLORING AGING WELL FOR HIV-INFECTED AND NON-INFECTED OLDER PEOPLE. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.4478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
145
|
Perlman A, Shah R, Bennett D, Buchman A, Matok I. RISKS AND OUTCOMES ASSOCIATED WITH DECLINE IN MOBILITY. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.2653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
146
|
Patel RN, Corrigall D, Syme G, Hay V, Hammond T, Saverymuttu S, Shah R. PWE-099 Audit of elective and emergency surgery for crohn’s disease at a district general hospital: is there a role for exclusive enteral nutrition and the specialist ibd dietician? Nutrition 2017. [DOI: 10.1136/gutjnl-2017-314472.345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
147
|
LaGorio L, Shah R, Buchman A, Leurgans S, Bennett D. ASSOCIATION BETWEEN IMPAIRED SWALLOWING AND COGNITION IN HEALTHY OLDER ADULTS. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.606] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
148
|
Shah R, Foldyna B, Hoffmann U. Outcomes of anatomical vs. functional testing for coronary artery disease : Lessons from the PROMISE trial. Herz 2017; 41:384-90. [PMID: 27333988 DOI: 10.1007/s00059-016-4451-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
The development of coronary artery disease (CAD) is a major, final common pathway in heart disease worldwide. With a rise in stress testing and increased scrutiny on cost-effectiveness and radiation exposure in medical imaging, a focus on the relative merits of anatomic versus functional characterization of CAD has emerged. In this context, coronary computed tomography angiography (CCTA) is a noninvasive alternative to functional testing as a first-line test for CAD detection but is complimentary in its nature. Here, we discuss the design, results, and implications of the PROMISE trial, a randomized comparative effectiveness study of 10,003 patients across 193 sites in the United States and Canada comparing the prognostic and diagnostic power of CCTA and standard stress testing. Specifically, we discuss the safety (e. g., contrast, radiation exposure) of CCTA versus functional testing in CAD, the need for improved selection for noninvasive testing, the frequency of downstream testing after anatomic or functional imaging, the use of imaging results in clinical management, and novel modalities of CAD risk determination using CCTA. PROMISE demonstrated that in a real-world, low-to-intermediate risk patient population referred to noninvasive testing for CAD, both CCTA and functional testing approaches have similar clinical, economic, and safety-based outcomes. We conclude with open questions in CAD imaging, specifically as they pertain to the utilization of CCTA.
Collapse
|
149
|
Shah V, Barwad P, Vyas A, Dedhia A, Shah R, Bachani N, Lokhandwala Y. P1616Clinical profile and intermediate term outcome of 50 consecutive patient of ventricular tachycardia storm managed at a tertiary care center in india. Europace 2017. [DOI: 10.1093/ehjci/eux158.242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
150
|
Maize KM, Shah R, Strom A, Kumarapperuma S, Wagner CR, Finzel BC. A structure-based guide to building hHint-1 activated nucleotide prodrugs. Acta Crystallogr A Found Adv 2017. [DOI: 10.1107/s0108767317097069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|